WIPO trademark

Threepoint

MixedWIPOClass 5Class 42

"Threepoint" is a trademark owned by Contera Pharma A/S, filed at the WIPO on July 7, 2026. It is on file and covers classes 5 and 42.

View Contera Pharma A/S portfolioGet this data via the API
Threepoint
Trademark as filed with the WIPO
Status
Mixed
Filed
July 7, 2026
Registered
Not yet
Expires
July 7, 2036
Application no.
Not recorded
Registration no.
1937613
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
2 classes
Ownership

Who owns Threepoint

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Contera Pharma A/S

Denmark

5 trademarks in the portfolioView company

Representative

De Fries & Tufekovic IP Aps

De Fries & Tufekovic IP Aps

Goods and services

What the mark covers

The products and services Threepoint is filed for, grouped by Nice class.

  • Drugs for medical purposes; medicines for human purposes; pharmaceutical preparations; chemical preparations for pharmaceutical purposes; DNA and RNA for medical purposes; antibiotics; antivirals.

  • Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modeling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); designing and implementing multiplexed high-throughput assays to screen for small molecules that modulate RNA processing using bioinformatic tools; designing and developing algorithms and thermodynamic models.

FAQ

About Threepoint

Who owns the trademark "Threepoint"?

The WIPO trademark "Threepoint" is owned by Contera Pharma A/S.

What is the status of "Threepoint"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Threepoint and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_6aa959c8-214a-4869-96cc-f6225f9658fa
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_6aa959c8-214a-4869-96cc-f6225f9658fa",
  "object": "trademark",
  "mark_text": "Threepoint",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2026-07-07",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Contera Pharma A/S",
      "entity_id": "ent_019eb7d3-2b14-74e9-a72f-06305e02aa9d"
    }
  ]
}